Root Financial Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-335
Closed -$7.18K 1083
2026
Q1
$7.18K Buy
335
+329
+5,483% +$4.64K ﹤0.01% 1807
2025
Q4
$56 Buy
+6
New +$50 ﹤0.01% 2372

Other funds holding DAWN

Root Financial Partners's DAWN Position: Q2 2026 in Review

Root Financial Partners sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 335 shares — an estimated $7.18K sold.

Root Financial Partners first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $7.18K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Root Financial Partners reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 335 Day One Biopharmaceuticals shares in Q2 2026, an estimated $7.18K.
  • Root Financial Partners first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Root Financial Partners's Day One Biopharmaceuticals position peaked at $7.18K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.